AbbVie (ABBV) Approves $1.5B Buyback
AbbVie, Inc. (NYSE: ABBV) authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: AbbVie (ABBV), Bristol-Myers Squibb (BMY) Announce EMA Validates, Grants Accelerated Assessment for Empliciti MAA
- Praxair (PX) Declares $0.715 Quarterly Dividend; Approves $1.5B Common Stock Repurchase Program
- Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
Create E-mail Alert Related CategoriesStock Buybacks
Related EntitiesStock Buyback
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!